Market Research Report Pipeline Review of Protein Kinase C Epsilon Type | Page 2

Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Overview 6
Therapeutics Development 7
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Products under Development
by Stage of Development 7
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Products under Development
by Therapy Area 8
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Products under Development
by Indication 9
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products 11
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Products under Development
by Companies 12
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Therapeutics Assessment 14
Assessment by Monotherapy/Combination Products 14
Assessment by Mechanism of Action 15
Assessment by Route of Administration 17
Assessment by Molecule Type 18
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Companies Involved in
Therapeutics Development 20
Hadasit Medical Research Services & Development Ltd 20
VM Discovery, Inc. 21
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Drug Profiles 22
Bryostatin-1 - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Request for Free Sample Report

DHACP-6 - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
Small Molecule to Activate Epsilon PKC for Ischemic Stroke - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
Small Molecule to Activate Epsilon PKC for Traumatic Brain Injury - Drug Profile 29
Product Description 29